Breast Cancer Gene (BRCA) Mutations Treatment Market Forecast 2026–2030 Highlighting Expansion Across Industries

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Breast Cancer Gene (BRCA) Mutations Treatment Market From 2026 To 2030?

The breast cancer gene (brca) mutations treatment market has demonstrated robust expansion in recent years. This market is projected to increase from $5.01 billion in 2025 to $5.37 billion in 2026, growing at a compound annual growth rate (CAGR) of 7.2%. During the historic period, this growth was influenced by factors such as limited awareness of brca mutations, restricted access to genetic testing services, a reliance on conventional chemotherapy, the increasing incidence of breast and ovarian cancer, and the gradual adoption of targeted therapies.

The breast cancer gene (brca) mutations treatment market size anticipates substantial expansion over the upcoming years. This market is projected to reach $7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is largely driven by strides in genomic sequencing technologies, broader applications for PARP inhibitors, escalating investments in precision oncology, a surge in the use of combination therapies, and favorable reimbursement policies supporting genetic testing and targeted treatments. Key trends shaping the forecast period encompass an uptick in the embrace of genetic testing and early BRCA mutation screening, the increasing application of PARP inhibitors within targeted therapies, a heightened emphasis on preventive and risk-reduction treatment strategies, the broadening of personalized and precision oncology methods, and enhanced availability of diverse treatment options for BRCA-related cancers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27231&type=smp

What Leading Drivers Are Supporting The Breast Cancer Gene (BRCA) Mutations Treatment Market Expansion?

A growing need for targeted therapies is projected to drive the expansion of the breast cancer gene (BRCA) mutation treatment market moving forward. These medical interventions specifically target cancer cells by focusing on genetic mutations or proteins crucial for cancer growth. The increasing adoption of targeted therapies is primarily due to their capability to precisely attack disease-causing cells or molecules while preserving healthy tissues, leading to better treatment outcomes and fewer side effects compared to conventional treatments. Targeted therapies enhance the treatment of breast cancer gene (BRCA) mutations by offering precision medicines that directly address the genetic alterations causing the disease, thereby improving patient results and minimizing unwanted side effects. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of Q1 2023, there were 247 gene therapies in Phase II, this number rose by 5% and reached 260 by the end of Q2 2023. Thus, the rising demand for targeted therapies is propelling the growth of the breast cancer gene (BRCA) mutation treatment market.

How Is The Breast Cancer Gene (BRCA) Mutations Treatment Market Segmented Across Different Segment Categories?

The breast cancer gene (brca) mutations treatment market covered in this report is segmented –

1) By Treatment Type: Targeted Therapies, Chemotherapy, Hormonal Therapy, Immunotherapy

2) By Indication: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer

3) By Administration Route: Oral, Intravenous, Subcutaneous

4) By End-User: Hospitals, Clinics, Cancer Specialty Clinics

Subsegments:

1) By Targeted Therapies: Poly (ADP-Ribose) Polymerase Inhibitors, Mammalian Target Of Rapamycin Inhibitors, Cyclin-Dependent Kinase 4 And 6 Inhibitors, Tyrosine Kinase Inhibitors

2) By Chemotherapy: Platinum-Based chemotherapy, Anthracyclines, Taxanes, Antimetabolites

3) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Selective Estrogen Receptor Degraders (SERDs), Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

4) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies

Which Organizations Play A Role In The Breast Cancer Gene (BRCA) Mutations Treatment Market Landscape?

Major companies operating in the breast cancer gene (brca) mutations treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GSK plc, Janssen Biotech Inc., Astellas Pharma Inc., Genentech Inc., Clovis Oncology Inc., Owkin Inc., Allarity Therapeutics Inc., VBL Therapeutics

Get The Full Breast Cancer Gene (BRCA) Mutations Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/breast-cancer-gene-brca-mutations-treatment-global-market-report

Which Region Is The Largest In The Breast Cancer Gene (BRCA) Mutations Treatment Market?

North America was the largest region in the breast cancer gene (BRCA) mutations treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer gene (brca) mutations treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Breast Cancer Gene (BRCA) Mutations Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/breast-cancer-gene-brca-mutations-treatment-global-market-report

Browse Through More Reports Similar to the Global Breast Cancer Gene (BRCA) Mutations Treatment Market 2026, By The Business Research Company

Converted Paper Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/converted-paper-products-global-market-report

Decorative Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/decorative-concrete-global-market-report

Concrete Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/concrete-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795